Conference Information

WELCOME MESSAGE

Genetic Engineering Conference 2023 brings together scientific specialists who have updated their knowledge of genetic engineering and human genetic disorders. Speakers will include genetic counselors, genomics healthcare scientists, pharmacologists, genetic epidemiologists, geneticists, CEOs, directors, vice presidents, co-executives, managing directors, genetic engineering scientists, and students from various professions.

Genetic Engineering Conference 2023 cordially invites all participants who are interested in sharing their knowledge and research in Genetics and Human Genetic Disorders to attend the “2nd Annual Congress on Genetic Engineering and Human Genetic Disorder” set on Mar 27-29, 2023, in London, UK.

Genetic Engineering Conference 2023 offers the scientific community a platform to share their knowledge within the field of Genetic Engineering and Human Genetic Disorder and Genetic Diseases. This Genetic Engineering Conference 2023 provides a complete programme given through two plenary sessions and panel discussions for the benefit of professionals working in the fields of Medical, Dental, Pharmacy, Nursing, and others who are dealing with common health issues.

This Genetic Engineering Conference 2023 will feature sessions from leading experts in genetic disease research, personalized and targeted medicine, local and international professors, physicians, and government representatives. The plenary and panel sessions aim to stimulate conversations on early diagnosis, increase access and quality care, maximize provider service coordination, and foster high-impact clinical research to accelerate the development of better medical therapies. The Genetic Engineering Conference 2023 primary goal is to educate medical professionals and provide accurate information to at-risk populations since these are the most cost-effective strategies to manage genetic illnesses among people from all over the world.

We plan to investigate the issues faced by genetic illnesses and the most current advances in pathogenesis, diagnosis, therapy, and prevention, focusing on the population. Indeed, this may improve awareness among medical experts in order to give appropriate preventative and treatment approaches.

MARKET ANALYSIS

The Genetic Engineering Conference 2023 will provide you with an overall analysis of the global market as well as regional markets. This genetic engineering conference will provide you with details about the products, equipment, drug diagnosis, therapeutic equipment, and how these things perform in the European market as well as in the United Kingdom.

Genetics market analysis, size, share, growth, trends, and forecast 2017-2026. During the projected period, the global genetic market is expected to develop at a robust CAGR of 11.5%. (2017-2026). The worldwide genetic market was worth $7749.00 million in 2017 and is predicted to be worth &25948.46 million by 2026, increasing at a CAGR of 14.37% during the forecast period. Europe, along with the United States, is a successful management in human genetics. The European market for human genetics is expanding rapidly. By the end of 2023, the estimated value will be USD2253.10Mn.

Zone survey of Global Genetic Market:

U.S:

America has the greatest market for human genetics due to its massive expansion. The human genetics market in the United States is expected to reach USD 19.99 billion in 2023, rising at a CAGR of 9.9% during the forecast period.

Europe:

The European market was valued at USD 1.22 billion in 2017 and is expected to grow to USD 1.8 billion by 2021. During the projection period, the annual growth rate (CAGR) will be 8.2%.

Companies in the United Kingdom are always competing with one another. especially since London is the market hub of the United Kingdom. The Genetic Engineering Conference may be the best opportunity to learn about market sites and discuss them with experts in genetics and genomics.

Asia Pacific:

The market is expected to grow by 9.3% to USD 5.30 billion by 2021, up from USD 3.39 billion in 2017. China's main growth rate is predicted to be 13.2% throughout the projection period.

Middle East:

The worldwide Human genetics market is predicted to reach $419.4 million in 2017 and to increase at a 13.9% annual pace over the following five years.

Segmentation:

R&D businesses, Genetics & Genomic companies, Medical research laboratories, Academic medical institutes and universities are among those expected to contribute to the growth of the worldwide Human genetics market. The worldwide Human genetics market is segmented into instruments, methodologies, applications, and end users.

During the projected period, the global human genetics market is expected to develop at a high CAGR of 11.5%. (2017-2026). It should be noted that the worldwide genetic market was worth $7749.00 million in 2017 and is predicted to be worth $25948.46 million by 2026, increasing at a CAGR of 14.37% over the forecast period.

Key players:

Agilent technologies (U.S.)
Bode technologies (U.S.)
GE Healthcare(U.K.)
Illumine(U.S.)
Orchid Cellmark,Inc(U.S.)
QIAGEN N.V(Netherland)

SESSIONS AND TRACKS

https://geneticengineering.cmesociety.com/registrationTrack 1: Healthcare

Businesses in the healthcare industry offer medical services, produce medical equipment or medications, provide medical insurance, or otherwise enable the delivery of healthcare to patients. A few key criteria characterise healthcare markets economically. Government involvement in healthcare markets and activities is common as a result of some of these economic considerations. Healthcare service demand is very price inelastic. Consumers and producers have inherent uncertainty about their requirements, outputs, and service prices. Patients, providers, and other industry participants all have asymmetric knowledge, therefore principal-agent issues are common. The healthcare industry encompasses a wide range of enterprises, from research to production to facility management.

· Medicine and Health

· Careers in Health Care

· Health Care Technologies

· Healthcare services

Related Conferences:

Related Associations:

American Society of Human Genetics (ASHG), Australasian Association of Clinical Geneticists, International Centre for Genetic Engineering and Biotechnology, Genome-Wide Association Studies (GWAS), National Human Genome Research Institute, Inoki Genome Federation, Global Alliance for Genomics and Health (GA4GH).

Associated Journals:

Associated Societies:

Track 2: Human Genetics

Human genetics is concerned with the study of human genetic heredity. Recent human genetics research is attempting to unravel the causes of lung cancer. The genetic and host variables that cause the progression of non-small cell lung cancer pre-invasive lesions. The mutation burden rises when lesions in the airway develop from AAH to invasive illness as a consequence of whole-exome sequencing of pre-invasive lesions and LUADs.

· Molecular biology

· Stem cells

· Genome

· Karyotypes

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 3: Molecular Genetics

Molecular Genetics examines the structure and function of genes at the molecular level. It works with both molecular biology and genetic systems. The most recent advancement is based on the use of DNA as a biological lens. It's a new cell study that discusses DNA microscopy, a technology that employs DNA sequencing to produce pictures of the spatial distribution of cell biomolecules without direct viewing.

· Developmental biology

· Gene expression

· Chromosomal studies

· Basic metabolic studies

· Bioscience

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 4: Medical genetics

Medical genetics research is based on the evolution that resulted in humans being 'fat.' In this study, human fat is collected, compared to other primitives, and analysed to determine if it is good or harmful fat. As medical genetics focuses on the detection and treatment of inherited illnesses, Medical Genetics is gaining traction in areas such as gene therapy, personalised medicine, and predictive medicine.

· Immunogenetics

· Pharmacogenetics

· Biochemistry

· Percision Medicine

· Biostatistics

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 5: Population genetics

The current study is discovering the genetic links between European, Mediterranean, and South-West Asian populations, which is a branch of evolutionary biology and a subdivision of genetics dealing with genetic differences among populations. A significant number of populations have been examined in population genetics and are being applied to fresh population samples. The current reference library of population samples enables global inference of new sample relationships.

· Describing the pitch of genetic variation

· Perceiving selection

· Demographic interference

· Evolution of genetic systems

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 6: Pediatrics and Genetics

Pediatric geneticists are often educated to detect the aetiology of these illnesses as well as their natural history. They may also recommend testing and therapies to help you understand and care for your child's condition. Similarly, the majority of infants are born healthy, with no medical issues or birth deformities. Some children, however, are born with variations in body shape, brain development, or body chemistry, which can lead to issues with health, development, school performance, and/or social interaction.

· Birth defects

· Brain development

· Body chemistry

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 7: Statistical Genetics

Statistical genetics is an emerging discipline that is often utilised in the context of human genetics. It is concerned with the statistical approach for deriving inferences from genetic data. The investigation of gene modules in single cell RNA-seq data using the tool MTGO-SC, which is the crucial step in the discovery of functional modules in gene interaction networks for understanding biological processes, is a new advance in statistical genetics.

· Population Genetics

· Genetic Epidemiology

· Quantitative Genetics

· Bioinformatics

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 8: Genetic Disorders

Genes are the foundation of inheritance. They are handed down from generation to generation. They contain DNA, which contains the instructions for producing proteins. Proteins do most of the tasks in cells. They transport molecules, build structures, destroy toxins, and perform a variety of other maintenance tasks. Single-gene diseases are one of three categories of genetic ailments in which a mutation affects just one gene. One example is sickle cell anaemia. When chromosomes (or portions of chromosomes) are absent or altered, chromosomal disorders arise.

Our genes are housed in structures called chromosomes. Down syndrome is a chromosomal disorder. Mutations in two or more genes create complex disorders. Your lifestyle and circumstances may also have a role. One example is colon cancer.

· Asthma and Allergy

· Heart disease

· Hypertension

· Infertility

· Diabetes

· Obesity

· Cancer

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 9: Genomics

Genomics is the study of the structure, function, evolution, mapping, and modification of genomes. Genomic has developed with new discoveries such as nanopore technology for sequencing human genomes. Nanopore technology has been widely utilised to sequence the genomes of bacteria and viruses. Nano pore human genome sequencing identifies structural differences in patient samples with great precision.

· Proteomics

· Bioinformatics

· Pharmacogenomics

· Metagenomics

· Computational biology

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 10: Clinical genetics

Clinical genetics is concerned with the correct treatment of uncommon diseases. Clinical genetics necessitates the use of a standard formula. They include clinical history taking, physical examination, genetic testing, genetic counselling, skin biopsies, clinical snapshots, and the use of computerised databases. The identification and validation of methylated-differentially expressed genes in Helicobacter pylori that are activated by gastric cancer, as well as a novel genetic cause of male infertility, are making headlines. Several diagnostic procedures were done on a few guys and their parents in order to discover the Novo mutation by comparing parental DNA with that of the kids.

· Diagnostic testing

· Presymptomatic and predictive testing

· Carrier testing

· Pharmacogenetics.

· Prenatal testing

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 11: Gene mutation

Gene Mutation is the modification of the nucleotide sequence of an organism's, virus's, or extrachromosomal DNA's genome. The trending immunodeficiency disorders caused by genetic mutation have been recognised by the experts. The researchers discovered that the babies had inflammatory bowel illness. The mutation in this condition meant that natural killer cells were unable to mature correctly, resulting in a decline in immune cells.

· Harmful mutation.

· Beneficial mutation.

· Prion mutation

· Somatic mutation

· Amorphic mutation

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 12: Gene Mapping

Gene mapping determines the location of the gene as well as the distance between genes. The creation of genetic markers and a mapping population can be used to create a genetic map. The most recent study focuses on recreating recent population history while mapping uncommon mutations using haplotypes. The haplotype-based technique is used to characterize uncommon variations and map illness associated with alleles. Recently, two unusual IBD haplotypes associated with asthma patients were discovered utilizing inflammatory bowel disease mapping.

· Molecular marker

· Genome sequencing

· Electrophoresis

· Restriction enzymes

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 13: Genetic analysis of DNA structure

DNA is a double helix structure made of two chains of molecules that are wrapped around each other to convey genetic instructions for the creation and growth of organisms. Scientists have just discovered a novel DNA structure inside the human cell called as "i-motif." It resembles a DNA tangle. The researchers are now working to determine the function of the novel DNA. They believe it will be utilised to read DNA sequences.

· Genetic Engineering

· DNA profiling

· DNA enzymes

· DNA nanotechnology

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 14: Gene Therapy

Gene therapy is the therapeutic delivery of nucleic acid into a patient's cells to address diseases. To introduce foreign DNA into patients, bone marrow transplantation and organ transplantation in general have been initiated. The success of gene therapy was achieved through limited clinical studies, which shown that it may safely treat the immune systems of newborns with uncommon life-threatening illnesses. Children with X-linked severe combined immunodeficiency were given experimental gene therapy, which showed that their immune systems improved and they grew normally up to the age of two.

· Somatic cell type

· Germ line cell type

· Gene expression

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 15: Genetic counselling

Helping couples, families, and individuals understand their inherited genetic condition to make health decisions is proposed by a genetic counsellor. A novel genetic abnormality causing intellectual impairment has been identified. The genetic mutation that causes X-linked syndrome intellectual disability is carried and passed on to offspring by unaffected females, but an interesting note is that the symptoms are observed in males such as behavioural issues, small average brains, and testes.

· Cardiovascular genetics

· Hereditary cancer genetics

· Neuro genetics

· Paediatric genetics

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 16: Genetic Epidemiology

The area of genetic epidemiology is distinguished by a confluence of methodologies derived from traditional studies of disease transmission, population and family-based studies of disease transmission, measurements, and, crucially, bioinformatics. Explicit elements of these controls are applied to the investigation of quality and condition, as well as the examination of quality and condition collaboration. Both quantitative and subjective characteristics may be intriguing. The research of disease transmission employs unique case-control, family, and population-based approaches, as well as genotyping from various sources.

· Molecular Epidemiology

· Statistical Genetics

· Behaviour genetics

· Bioinformatics

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 17: Chromosomal abnormality

Recent reviews have solely focused on cancer in the sense that renal carcinoma arises due to chromosomal abnormality, in which chromosome translocation happens often, where a portion of one chromosome can be discovered connected to another. Chromosome abnormalities are classified into two types: numerical abnormalities and structural abnormalities. The numerical abnormality is caused by a chromosome or chromosomes that have been altered. The structural abnormality is a change in the chromosomal structure.

· Numerical disorders

· Structural disorders

· Replication of DNA

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 18: Cytogenetic

Cytogenetics is the study of chromosomal structure, gene placement on chromosomes, and chromosomal behavior during cell division. Ongoing chromosomal instability and karyotype evolution in human colorectal cancer organoids, as well as in vitro and in vivo evaluation of DNA interaction, genotoxicity, and oxidative stress induced by iron oxide nanoparticles, because iron particles are known to induce cytotoxicity in various cancer cell lines via reactive oxygen species generation.

· Mitosis

· Meiosis

· Fluorescent in situ hybridization

· Comparative genomic hybridization

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 19: Neuro Genetics

Genetics and nervous system research are combined in a branch of science known as neurogenetics, which is concerned with the turn of events and capability of the sensory system, as well as the claimed features in its turn of events. In hereditary qualities, the term "aggregate" refers to a living being's real features or attributes, whereas "genotype" refers to a creature's genetic cosmetics. In terms of the sensory system, "aggregate" may refer to differences in brain properties amongst persons of comparable species, whereas "genotype" refers to the hereditary make-up that determines the numerous characteristics transmitted by particular biological entities.

For example, many of the conditions that belong under the banner of neurogenetics, for example, Alzheimer's, Huntington's, and epilepsy, are still significant objects of investigation today, and much is now known about the hereditary basis of these and countless other conditions.

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 20: Diagnosis & Prognosis of Inborn Disorders

Because of the gene's poor understanding, genetic diagnosis remains out of reach for many people suffering from uncommon disorders. Gene testing is a method of diagnosing heritable features that involve the identification of alleles, mutations, genotypes, and karyotypes. The most recent advancement in gene testing is the characterization of Craniofrontonasal syndrome, an X-linked developmental condition caused by EFNB1 mutations, and it demonstrates the lack of association between the mutation type, severity, and manifestation of symptoms.

· Down syndrome

· Muscular dystrophy

· Huntington’s disease

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 21: Remedy for Hereditary Ailments

Recently, research has begun to develop a cure for hereditary illnesses. As a result, new research comprising integrated genomic and transcriptome analysis of dual hepatocellular-intrahepatic cholangiocarcinoma tumors with diverse clinical and molecular characteristics that might be utilized to guide therapy options has been found. The search for a treatment for genetic illnesses is an ongoing one, with a great number of clinical trials conducted. Despite this, some therapy strategies focus on managing the symptoms of the diseases in order to improve the quality of life.

· Bone marrow transplantation

· Palliative care

· Stem cell treatment

· Drug intervention

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 22: Ethical and Legal Issues

In the recent decade, several ethical, legal, and social concerns (ELSI) about genetic testing and research have been raised. These issues should be discussed with patients so that they are informed of the risks and benefits of genetic testing and can utilise it safely and correctly. This chapter provides a brief overview of some of the most urgent ELSI concerns about genetic testing. Concerns have been expressed regarding the usage and potential exploitation of genetic data. Concerns range from the analytical and clinical validity of a genetic test to the perceived stigma of having a genetic difference to the duty of disclosing genetic information to potentially impacted persons.

· Communicating test results

· Direct-to-consumer tests

· Duty to disclose

· Genetic discrimination

· Psychosocial impact

· Reproductive issues

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 23: Cancer Genetics

Cancer is triggered by alterations in genes that determine how our cells work, according to genetics. Some gene alterations can cause cells to develop abnormally and become cancerous.

· Clinical Oncology

· Oncogenes

· Genetic Testing

· Hereditary Cancer

· Genetic Changes

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 24: Reproductive Genetics / Prenatal Genetics

In health care, reproductive genetics focuses on genetic risks or disorders that can be handed down from parent to kid via their genes during pregnancy. Genes code for our characteristics, including elements of our health. Everyone has a few genes that do not function properly because of little alterations (mutations) inside them. Most of the time, these mutations have no effect on our health, and we are unaware that we have them. Our child may or may not inherit these mutations from us in the genes we pass down, which may or may not create health problems in our child.

· Non-invasive prenatal testing

· Invasive diagnostic testing

· Pre-implantation genomic diagnosis

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

Track 25: Plant Genetics and Genomics

Plant genetics is the study of heredity in plants, especially hereditary transmission processes and the diversity of inherited features. Plant genetics differs from animal genetics in three ways: somatic mutations contribute more easily to the germ line because flowers arise at the end of somatic cell-based branches; polyploidy is more prevalent; and plants have chloroplast DNA.

Plant genomes are best defined by genome size, gene content, the presence of repetitive sequences, and polyploidy/duplication events. It aims to sequence, characterise, and analyse the genetic compositions, structures, organisations, functions, and interactions/networks of a whole plant genome. Plants also contain mitochondrial and chloroplast genomes, but the nuclear genome is the biggest and most complex. Plant Genomics is Important for Food Security, Human Health, and Environmental Sustainability.

· Epigenetics

· Gene Regulation and Transcriptional Networks

· Genome Editing

· Comparative Genomics

Related Conferences:

Related Associations:

Associated Journals:

Associated Societies:

ABOUT THE CONFERENCE

PULSUS Conferences take honor and pleasure in welcoming the participants for the “2nd Annual Congress on Genetic Engineering and Human Genetic Disorder” set on Mar 27-29, 2023, in London, UK. By assembling scientific specialists for the enthralling event, we take a giant step toward Genetic Engineering Conference 2023.

The Genetic Engineering Conference 2023 is themed “Perspective towards modern automation in Genetics” and aims to promote the world's most prominent scientific specialists in the fields of Genetics and Illnesses, Molecular genetics, Genomics, Gene mutation, Clinical genetics, and hereditary disorders.

Genetic Engineering Conference 2023 is the appropriate combination of circumstances to outstretch the convergence of the partaker throughout the planet. Let us combine, demonstrate, transfer, and collaborate with the most recent technologists to investigate the subjects of Genetic Engineering and Genetic Disorders and curative measures for genetic disorders, which gives the best impression with new drug innovations and developments, and receive name recognition and certificates from our world-class prestigious committee members during these three days. The Genetic Engineering Conference 2023 hallmarks include famous speakers from around the world, the latest methodology, progress, and news in Genetic engineering and Human Genetic Disorder, and associated debates.

Join us for Genetic Engineering Conference 2023, a rare agreement that will bring together the world's most famous industrialists and researchers in the fields of Genetic Engineering and Genetic Disorders, Gene Therapy, Cytogenetics, and more.

WELCOME MESSAGE

Genetic Engineering Conference 2023 Conference offers the scientific community a platform to share their knowledge within the field of Genetic Engineering and Human Genetic Disorder. This conference provides a complete programme given through two plenary sessions and panel discussions for the benefit of professionals working in the fields of Medical, Dental, Pharmacy, Nursing, and others who are dealing with common health issues.

This conference will feature sessions from leading experts in genetic disease research, personalized and targeted medicine, local and international professors, physicians, and government representatives. The plenary and panel sessions aim to stimulate conversations on early diagnosis, increase access and quality care, maximize provider service coordination, and foster high-impact clinical research to accelerate the development of better medical therapies. The Genetic Engineering Conference 2023 primary goal is to educate medical professionals and provide accurate information to at-risk populations since these are the most cost-effective strategies to manage Genetic Disorders among people from all over the world.

AIM OF THE CONFERENCE

Genetic Engineering Conference 2023 lays the groundwork for enhanced refurbishment in the fields of genetic engineering and human genetic disorder, as well as the prevention of genetic disorders causes. Several scientific sessions, symposiums, and poster presentations are scheduled for Genetic Engineering Conference 2023. It is a global forum for learning and discussing Genetics & Human diseases and their connected topics in clinical genomics, genetic counselling, cancer genetics, genetically-related medical devices, and more.

CONFERENCE HIGHLIGHTS

1. The conference provides a fantastic chance to exchange scientific information and experiences with world-renowned participants in Genetics and Human Genetic Disorders.

2. The debates in Genetic Engineering Conference 2023 are on technological development, innovation, and research in Genetics and Human Genetic Disorders, Genomics, Molecular genetics, Clinical genetics, medical genetics, diagnosis, treatment, and gene therapy.

CONFERENCE ATTENDEES:

• Medical Institutions and Hospitals' Deans/Chairs, Vice Deans, and Vice Presidents

• Academic professors and students working in the field of research, medical and clinical research

• Physicians, Business delegates, Directors/Managers/Business Intelligence experts, and Departmental Managers

TARGET AUDIENCE OF GENETICS ENGINEERING CONFERENCE 2023:

1. Genomics and Genetics Students

2. Genomics and Pharmacogenomics Researchers

3. Genomics and Pharmacogenomics Faculty

4. Genomics Scientists

5. Genomics Colleges

6. Genetic Disorder Scientists

7. Pharmacology Health Professionals